//3 vaccine executives say that after approval, distribution will be the main challenge

3 vaccine executives say that after approval, distribution will be the main challenge

Pfizer, Moderna and Johnson & Johnson are working to produce enough doses and ensure fair distribution through the uneven U.S. health care system.